

Cover Story
Editorial
On Nov. 5, as the American people expressed their will, electing Donald Trump to a second term, I started to wonder what my friends in oncology were thinking.
In Brief


Clinical Roundup




Trending Stories
- Brawley: ACS prostate cancer screening guideline should say no to “mass screening”
- NCI’s Letai, FDA’s Diamantas identify strategies to speed up cancer trials
Letai: 150 days to start a cancer trial is too long—cancer centers need to accept a little risk - USPSTF convenes first meeting in over a year
- Cancer Grand Challenges awards $10M to research team aiming to develop AI “co-scientists”
AI agents would narrow the “incredibly large combinatorial universe of cancer questions” - Philadelphia cancer center directors talk city-wide collaboration
“A bench-to-bedside-to-block model” - The next revolution in cancer care may be manufactured at the bedside
As personalized mRNA cancer vaccines move toward clinical reality, the challenge will be to make them broadly available
















